Novo Nordisk, Eli Lilly and TrumpRx
Digest more
Indianapolis, Indiana-based Eli Lilly and Company (LLY) discovers and develops various drugs and medicines. It operates as ...
In the preceding three months, 12 analysts have released ratings for Eli Lilly (NYSE: LLY ), presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...
On May 12, 2025, President Trump signed an Executive Order titled: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” directing the Administration to take numerous actions ...
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...
Detailed price information for Goldman Sachs Group (GS-N) from The Globe and Mail including charting and trades.
Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity ...
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback